Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 4 | 2016 | 303 | 0.710 |
Why?
|
| CA-125 Antigen | 1 | 2014 | 9 | 0.510 |
Why?
|
| Postmenopause | 1 | 2014 | 125 | 0.480 |
Why?
|
| Gestational Age | 3 | 2017 | 190 | 0.310 |
Why?
|
| Patient Readmission | 2 | 2018 | 74 | 0.290 |
Why?
|
| Pre-Eclampsia | 2 | 2016 | 57 | 0.270 |
Why?
|
| DNA Mismatch Repair | 2 | 2016 | 24 | 0.260 |
Why?
|
| Early Detection of Cancer | 2 | 2016 | 292 | 0.230 |
Why?
|
| Pregnancy | 8 | 2021 | 1503 | 0.230 |
Why?
|
| General Surgery | 1 | 2022 | 20 | 0.230 |
Why?
|
| Food Supply | 1 | 2023 | 99 | 0.210 |
Why?
|
| Genetic Markers | 1 | 2021 | 118 | 0.200 |
Why?
|
| Female | 17 | 2023 | 19873 | 0.200 |
Why?
|
| Diabetes, Gestational | 1 | 2021 | 46 | 0.200 |
Why?
|
| Internship and Residency | 1 | 2022 | 121 | 0.200 |
Why?
|
| Single Embryo Transfer | 1 | 2021 | 3 | 0.200 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2020 | 11 | 0.190 |
Why?
|
| Blastocyst | 1 | 2021 | 48 | 0.190 |
Why?
|
| Contraceptive Agents, Female | 1 | 2020 | 23 | 0.190 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 271 | 0.190 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2019 | 4 | 0.190 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 48 | 0.180 |
Why?
|
| Placenta | 2 | 2016 | 91 | 0.170 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 35 | 0.160 |
Why?
|
| Humans | 18 | 2023 | 34853 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 638 | 0.160 |
Why?
|
| Laminaria | 1 | 2017 | 3 | 0.160 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2017 | 6 | 0.160 |
Why?
|
| Hawaii | 6 | 2021 | 1878 | 0.150 |
Why?
|
| Aged | 7 | 2018 | 6448 | 0.150 |
Why?
|
| Sirtuin 3 | 1 | 2016 | 5 | 0.150 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2016 | 7 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 32 | 0.150 |
Why?
|
| Telomere | 1 | 2016 | 51 | 0.140 |
Why?
|
| Glucuronidase | 1 | 2016 | 14 | 0.140 |
Why?
|
| Middle Aged | 8 | 2018 | 9642 | 0.140 |
Why?
|
| Hypertension | 1 | 2023 | 770 | 0.140 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2015 | 6 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2015 | 17 | 0.130 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 38 | 0.130 |
Why?
|
| Retrospective Studies | 5 | 2021 | 1961 | 0.130 |
Why?
|
| Communication Barriers | 1 | 2015 | 53 | 0.130 |
Why?
|
| Precancerous Conditions | 1 | 2016 | 81 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 90 | 0.130 |
Why?
|
| Endometrial Neoplasms | 1 | 2016 | 64 | 0.130 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2014 | 14 | 0.130 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2014 | 17 | 0.130 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2014 | 14 | 0.130 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2014 | 18 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2016 | 179 | 0.120 |
Why?
|
| Language | 1 | 2015 | 143 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2015 | 183 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 239 | 0.120 |
Why?
|
| Mothers | 1 | 2015 | 164 | 0.120 |
Why?
|
| Mortality | 1 | 2014 | 150 | 0.110 |
Why?
|
| Stroke | 1 | 2016 | 274 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 221 | 0.110 |
Why?
|
| Adult | 8 | 2021 | 11034 | 0.110 |
Why?
|
| Hospitalization | 1 | 2015 | 370 | 0.110 |
Why?
|
| Heart Failure | 1 | 2015 | 230 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2014 | 727 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2014 | 1353 | 0.090 |
Why?
|
| Risk Factors | 4 | 2021 | 3414 | 0.090 |
Why?
|
| Young Adult | 4 | 2021 | 4012 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2015 | 583 | 0.090 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2016 | 10 | 0.070 |
Why?
|
| Trophoblasts | 2 | 2016 | 22 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 2333 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 1426 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 53 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2021 | 155 | 0.050 |
Why?
|
| Live Birth | 1 | 2021 | 8 | 0.050 |
Why?
|
| Menstruation | 1 | 2020 | 10 | 0.050 |
Why?
|
| Levonorgestrel | 1 | 2020 | 16 | 0.050 |
Why?
|
| Curriculum | 1 | 2022 | 237 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 254 | 0.050 |
Why?
|
| Genotype | 1 | 2021 | 641 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2023 | 613 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1056 | 0.040 |
Why?
|
| Sodium Bicarbonate | 1 | 2017 | 8 | 0.040 |
Why?
|
| Male | 4 | 2018 | 18870 | 0.040 |
Why?
|
| Lidocaine | 1 | 2017 | 15 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 16 | 0.040 |
Why?
|
| Diet | 1 | 2023 | 747 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2017 | 269 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 141 | 0.040 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2016 | 7 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2017 | 161 | 0.040 |
Why?
|
| Pregnancy, Ectopic | 1 | 2016 | 14 | 0.040 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2016 | 13 | 0.040 |
Why?
|
| Extraembryonic Membranes | 1 | 2016 | 6 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2016 | 10 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2016 | 33 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 34 | 0.040 |
Why?
|
| Menopause | 1 | 2016 | 54 | 0.030 |
Why?
|
| Abortion, Induced | 1 | 2017 | 82 | 0.030 |
Why?
|
| Parturition | 1 | 2015 | 22 | 0.030 |
Why?
|
| Perinatal Care | 1 | 2015 | 15 | 0.030 |
Why?
|
| Asia | 1 | 2015 | 74 | 0.030 |
Why?
|
| Child | 1 | 2023 | 2875 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 151 | 0.030 |
Why?
|
| Pacific Islands | 1 | 2015 | 115 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 859 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 112 | 0.030 |
Why?
|
| Endometrium | 1 | 2016 | 57 | 0.030 |
Why?
|
| Health Services Research | 1 | 2015 | 133 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2015 | 231 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 570 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1007 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 1003 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 5035 | 0.020 |
Why?
|
| United States | 1 | 2018 | 3894 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 2561 | 0.020 |
Why?
|